KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Net Cash Flow (2016 - 2025)

Idexx Laboratories has reported Net Cash Flow over the past 17 years, most recently at -$28.1 million for Q4 2025.

  • Quarterly results put Net Cash Flow at -$28.1 million for Q4 2025, down 164.83% from a year ago — trailing twelve months through Dec 2025 was -$119.4 million (up 23.53% YoY), and the annual figure for FY2025 was -$119.4 million, up 23.53%.
  • Net Cash Flow for Q4 2025 was -$28.1 million at Idexx Laboratories, down from $44.2 million in the prior quarter.
  • Over the last five years, Net Cash Flow for IDXX hit a ceiling of $201.6 million in Q3 2023 and a floor of -$122.0 million in Q1 2025.
  • Median Net Cash Flow over the past 5 years was -$9.8 million (2022), compared with a mean of -$9.7 million.
  • Biggest five-year swings in Net Cash Flow: soared 7091.35% in 2022 and later plummeted 3021.01% in 2024.
  • Idexx Laboratories' Net Cash Flow stood at $104000.0 in 2021, then soared by 7091.35% to $7.5 million in 2022, then surged by 1472.03% to $117.6 million in 2023, then tumbled by 109.02% to -$10.6 million in 2024, then tumbled by 164.83% to -$28.1 million in 2025.
  • The last three reported values for Net Cash Flow were -$28.1 million (Q4 2025), $44.2 million (Q3 2025), and -$13.5 million (Q2 2025) per Business Quant data.